Page contentsPage contents Shortage information Key facts Key dates Related medicine information Direct healthcare professional communication related to this shortage Shortage information Integrilin has now been discontinued and is no longer available. Key facts Medicines affected Integrilin Supply shortage status Medicine discontinued International non-proprietary name (INN) or common name eptifibatide Therapeutic area (MESH) Angina, UnstableMyocardial Infarction Pharmaceutical forms affected Solution for injectionSolution for infusion Strengths affected 2 mg/ml (solution for injection)0.75 mg/ml (solution for infusion) Availability of alternatives Yes Key dates First published 17/01/2024 Last updated 03/06/2026 Related medicine information Integrilin Information on shortages and national shortage registers Medicine Shortages Single Point of Contact (SPOC) Working Party National competent authorities (human) Eligible healthcare professionals' organisations Eligible patients and consumers' organisations Direct healthcare professional communication related to this shortageIntegrilin - direct healthcare professional communication (DHPC) Share this page